Amyotrophic lateral sclerosis, or ALS, or Lou Gehrig’s disease, destroys nerves that control muscles. It currently has only one FDA approved medication for treatment, which reportedly has only a marginal effect. Bioscience Technology reports, however, that an investigational new treatment for an inherited form of the disease has passed an early phase clinical trial. The…
ReadHuntington’s Disease is characterized by a build-up of abnormal proteins in the brain. A study at Massachusetts General Hospital has found that inhibiting a specific enzyme can slow many of the symptoms of HD, including loss of motor function and neurological damage. Unfortunately, a new drug will have to be designed to inhibit this enzyme,…
ReadA collaboration between the Boston University School of Medicine, the McLean Brain Tissue Resource Center, Massachusetts General Hospital and Columbia University produced breakthroughs in the understanding of Huntington’s disease and how it affects the brain. As reported on Medical Xpress, investigators involved in a study examined 664 donated brain samples with Huntington’s disease and observed…
Read
©2021 Brookhaven Hospital. All Rights Reserved.